Marketwatch has a list of five biotech stocks to own now, for a wide variety of reasons. The four names the author mentions are Cerus
CERS, Curis
CRIS, Compugen
CGEN, Spectrum Pharmaceuticals
SPPI, and Impax Laboratories
IPXL.
Regarding Cerus, the author says that the company has a technology that cleans donated blood of potential viruses, bacteria, parasites. The author believes the FDA will eventually approve the system, known as INTERCEPT Blood System. He sees it being worth $14 in a few years.
Curis has more than 20 drug trials ongoing with Roche Genentech with regards to cancer treatments. He thinks the stock could go to $40 from around $2 if the company hits with one of its trials.
To read about the other drugs and why they are potential buys, visit the article
here.
Disclosure: no position in names mentioned.
Loading...
Loading...
CERSCerus Corp
$1.32-1.49%
Edge Rankings
Momentum
21.30
Growth
20.03
Quality
Not Available
Value
64.12
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in